| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 6.76e-06 | 5 | 177 | 3 | GO:0004558 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 2.33e-05 | 7 | 177 | 3 | GO:0090599 | |
| GeneOntologyBiologicalProcess | maltose metabolic process | 5.80e-07 | 3 | 173 | 3 | GO:0000023 | |
| GeneOntologyBiologicalProcess | protein insertion into ER membrane | 5.58e-06 | 31 | 173 | 5 | GO:0045048 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 4.75e-05 | 9 | 176 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | distal axon | POLG CBARP DCC ZNF804A TENM2 NRP1 KCNA2 PTPRS DIXDC1 SLC2A13 UNC13A HSP90AA1 PINK1 | 8.46e-05 | 435 | 176 | 13 | GO:0150034 |
| GeneOntologyCellularComponent | ER membrane insertion complex | 1.99e-04 | 14 | 176 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | anchoring collagen complex | 2.10e-04 | 3 | 176 | 2 | GO:0030934 | |
| GeneOntologyCellularComponent | growth cone | 2.40e-04 | 245 | 176 | 9 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 3.04e-04 | 253 | 176 | 9 | GO:0030427 | |
| GeneOntologyCellularComponent | LUBAC complex | 4.18e-04 | 4 | 176 | 2 | GO:0071797 | |
| GeneOntologyCellularComponent | axon | GABRD POLG INSR CBARP DCC ZNF804A TENM2 NRP1 KCNA2 PTPRS DLG1 DIXDC1 SLC2A13 WDFY3 HCFC1 UNC13A HSP90AA1 PINK1 | 5.41e-04 | 891 | 176 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | basement membrane | 5.90e-04 | 122 | 176 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | somatodendritic compartment | GABRD PCSK5 INPP5A INSR SHROOM2 ZNF804A TENM2 LRIT3 LDLR RPH3A ABHD17C NRP1 KCNA2 PTPRS SHARPIN LRP6 DLG1 DIXDC1 WDFY3 KLHL14 HCFC1 HSP90AA1 | 6.68e-04 | 1228 | 176 | 22 | GO:0036477 |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 8.21e-04 | 179 | 176 | 7 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 8.21e-04 | 179 | 176 | 7 | GO:0030672 | |
| GeneOntologyCellularComponent | cell body | GABRD PCSK5 INSR SHROOM2 ZNF804A LRIT3 NRP1 KCNA2 PTPRS LRP6 DLG1 DIXDC1 SLC2A13 WDFY3 KLHL14 HCFC1 HSP90AA1 PINK1 | 8.76e-04 | 929 | 176 | 18 | GO:0044297 |
| GeneOntologyCellularComponent | sorting endosome | 1.03e-03 | 6 | 176 | 2 | GO:0097443 | |
| GeneOntologyCellularComponent | Atg12-Atg5-Atg16 complex | 1.03e-03 | 6 | 176 | 2 | GO:0034274 | |
| GeneOntologyCellularComponent | apical part of cell | SLC17A2 MGAM DUOX2 SHROOM2 LDLR PTH1R SLC19A1 DLG1 SLC2A13 MUC4 PCM1 HSP90AA1 TJP3 | 1.56e-03 | 592 | 176 | 13 | GO:0045177 |
| GeneOntologyCellularComponent | ficolin-1-rich granule membrane | 1.74e-03 | 61 | 176 | 4 | GO:0101003 | |
| GeneOntologyCellularComponent | neuronal cell body | GABRD PCSK5 INSR SHROOM2 ZNF804A LRIT3 NRP1 KCNA2 PTPRS LRP6 DLG1 DIXDC1 WDFY3 KLHL14 HCFC1 HSP90AA1 | 1.90e-03 | 835 | 176 | 16 | GO:0043025 |
| Domain | Ig-like_fold | TARM1 COL7A1 CRLF1 MYLK HLA-DOB TNC INSR DCC LRIT3 NOMO1 TGM1 CD1B HMCN1 IGHA1 PTPRM BTNL3 NOMO2 PTPRS MICB COL14A1 FCRL4 SDK1 HCFC1 IGLON5 NOMO3 IGSF3 | 2.08e-09 | 706 | 174 | 26 | IPR013783 |
| Domain | - | TARM1 COL7A1 CRLF1 MYLK HLA-DOB TNC INSR DCC LRIT3 NOMO1 TGM1 CD1B HMCN1 PTPRM BTNL3 NOMO2 PTPRS MICB COL14A1 FCRL4 SDK1 HCFC1 IGLON5 NOMO3 IGSF3 | 2.73e-09 | 663 | 174 | 25 | 2.60.40.10 |
| Domain | FN3 | COL7A1 CRLF1 MYLK TNC INSR DCC LRIT3 PTPRM PTPRS COL14A1 SDK1 HCFC1 | 1.69e-07 | 185 | 174 | 12 | SM00060 |
| Domain | FN3 | COL7A1 CRLF1 MYLK TNC INSR DCC LRIT3 PTPRM PTPRS COL14A1 SDK1 HCFC1 | 3.71e-07 | 199 | 174 | 12 | PS50853 |
| Domain | FN3_dom | COL7A1 CRLF1 MYLK TNC INSR DCC LRIT3 PTPRM PTPRS COL14A1 SDK1 HCFC1 | 6.27e-07 | 209 | 174 | 12 | IPR003961 |
| Domain | fn3 | 2.90e-06 | 162 | 174 | 10 | PF00041 | |
| Domain | DUF2012 | 3.16e-06 | 4 | 174 | 3 | PF09430 | |
| Domain | DUF2012 | 3.16e-06 | 4 | 174 | 3 | IPR019008 | |
| Domain | IG_LIKE | TARM1 CRLF1 MYLK HLA-DOB DCC LRIT3 CD1B HMCN1 IGHA1 PTPRM BTNL3 PTPRS MICB FCRL4 SDK1 IGLON5 IGSF3 | 3.58e-06 | 491 | 174 | 17 | PS50835 |
| Domain | Ig-like_dom | TARM1 CRLF1 MYLK HLA-DOB DCC LRIT3 CD1B HMCN1 IGHA1 PTPRM BTNL3 PTPRS MICB FCRL4 SDK1 IGLON5 IGSF3 | 4.94e-06 | 503 | 174 | 17 | IPR007110 |
| Domain | VWFA | 1.14e-05 | 82 | 174 | 7 | PS50234 | |
| Domain | VWA | 1.32e-05 | 56 | 174 | 6 | PF00092 | |
| Domain | VWA | 1.34e-05 | 84 | 174 | 7 | SM00327 | |
| Domain | Glyco_hydro_31_AS | 1.56e-05 | 6 | 174 | 3 | IPR030458 | |
| Domain | CarboxyPept-like_regulatory | 1.58e-05 | 17 | 174 | 4 | IPR008969 | |
| Domain | Glyco_hydro_31 | 2.71e-05 | 7 | 174 | 3 | IPR000322 | |
| Domain | Glyco_hydro_31 | 2.71e-05 | 7 | 174 | 3 | PF01055 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 2.71e-05 | 7 | 174 | 3 | PS00129 | |
| Domain | VWF_A | 3.91e-05 | 99 | 174 | 7 | IPR002035 | |
| Domain | Carb-bd-like_fold | 4.30e-05 | 8 | 174 | 3 | IPR013784 | |
| Domain | - | 6.58e-05 | 74 | 174 | 6 | 3.40.50.410 | |
| Domain | EGF | 7.32e-05 | 235 | 174 | 10 | SM00181 | |
| Domain | EGF-like_dom | 1.18e-04 | 249 | 174 | 10 | IPR000742 | |
| Domain | Kelch-typ_b-propeller | 1.58e-04 | 55 | 174 | 5 | IPR015915 | |
| Domain | CarboxyPept_regulatory_dom | 2.12e-04 | 13 | 174 | 3 | IPR014766 | |
| Domain | - | 2.12e-04 | 13 | 174 | 3 | 2.60.40.1120 | |
| Domain | Glyco_hydro_31_N_dom | 2.57e-04 | 3 | 174 | 2 | IPR025887 | |
| Domain | TRAM1 | 2.57e-04 | 3 | 174 | 2 | PF08390 | |
| Domain | RFX1_trans_act | 2.57e-04 | 3 | 174 | 2 | IPR007668 | |
| Domain | RFX1_trans_act | 2.57e-04 | 3 | 174 | 2 | PF04589 | |
| Domain | Gal_mutarotas_2 | 2.57e-04 | 3 | 174 | 2 | PF13802 | |
| Domain | Translocation_assoc_membrane | 2.57e-04 | 3 | 174 | 2 | IPR016447 | |
| Domain | TRAM1 | 2.57e-04 | 3 | 174 | 2 | IPR013599 | |
| Domain | IGc2 | 3.67e-04 | 235 | 174 | 9 | SM00408 | |
| Domain | EGF_3 | 3.67e-04 | 235 | 174 | 9 | PS50026 | |
| Domain | Ig_sub2 | 3.67e-04 | 235 | 174 | 9 | IPR003598 | |
| Domain | MHC_I/II-like_Ag-recog | 4.19e-04 | 38 | 174 | 4 | IPR011162 | |
| Domain | Gal_mutarotase_SF_dom | 4.91e-04 | 17 | 174 | 3 | IPR011013 | |
| Domain | Kelch_1 | 4.92e-04 | 70 | 174 | 5 | PF01344 | |
| Domain | Kelch_1 | 4.92e-04 | 70 | 174 | 5 | IPR006652 | |
| Domain | Glyco_hydro_31_CS | 5.11e-04 | 4 | 174 | 2 | IPR030459 | |
| Domain | Gal_mutarotase_N | 5.11e-04 | 4 | 174 | 2 | IPR031727 | |
| Domain | SAC3/GANP/THP3 | 5.11e-04 | 4 | 174 | 2 | IPR005062 | |
| Domain | NtCtMGAM_N | 5.11e-04 | 4 | 174 | 2 | PF16863 | |
| Domain | SAC3_GANP | 5.11e-04 | 4 | 174 | 2 | PF03399 | |
| Domain | IG | TARM1 MYLK DCC LRIT3 HMCN1 PTPRM BTNL3 PTPRS FCRL4 SDK1 IGLON5 IGSF3 | 6.02e-04 | 421 | 174 | 12 | SM00409 |
| Domain | Ig_sub | TARM1 MYLK DCC LRIT3 HMCN1 PTPRM BTNL3 PTPRS FCRL4 SDK1 IGLON5 IGSF3 | 6.02e-04 | 421 | 174 | 12 | IPR003599 |
| Domain | EGF_1 | 6.62e-04 | 255 | 174 | 9 | PS00022 | |
| Domain | EGF-like_CS | 7.81e-04 | 261 | 174 | 9 | IPR013032 | |
| Domain | GLYCOSYL_HYDROL_F31_2 | 8.47e-04 | 5 | 174 | 2 | PS00707 | |
| Domain | DUF4704 | 8.47e-04 | 5 | 174 | 2 | IPR031570 | |
| Domain | DUF4704 | 8.47e-04 | 5 | 174 | 2 | PF15787 | |
| Domain | EGF_2 | 8.70e-04 | 265 | 174 | 9 | PS01186 | |
| Domain | WD40_repeat_CS | 8.81e-04 | 164 | 174 | 7 | IPR019775 | |
| Domain | WD40 | 9.41e-04 | 268 | 174 | 9 | SM00320 | |
| Domain | - | 1.03e-03 | 48 | 174 | 4 | 2.120.10.80 | |
| Domain | WD40_repeat | 1.04e-03 | 272 | 174 | 9 | IPR001680 | |
| Domain | Quino_amine_DH_bsu | 1.07e-03 | 22 | 174 | 3 | IPR011044 | |
| Domain | WD_REPEATS_1 | 1.22e-03 | 278 | 174 | 9 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.25e-03 | 279 | 174 | 9 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.25e-03 | 279 | 174 | 9 | PS50294 | |
| Domain | PH_BEACH | 1.26e-03 | 6 | 174 | 2 | PF14844 | |
| Domain | MHC_I_3 | 1.26e-03 | 6 | 174 | 2 | PF16497 | |
| Domain | - | 1.39e-03 | 24 | 174 | 3 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 1.39e-03 | 24 | 174 | 3 | IPR011161 | |
| Domain | Glycoside_hydrolase_SF | 1.49e-03 | 53 | 174 | 4 | IPR017853 | |
| Domain | C1-set | 1.60e-03 | 54 | 174 | 4 | PF07654 | |
| Domain | IGc1 | 1.83e-03 | 56 | 174 | 4 | SM00407 | |
| Domain | WD40_repeat_dom | 1.91e-03 | 297 | 174 | 9 | IPR017986 | |
| Domain | Ig_I-set | 2.06e-03 | 190 | 174 | 7 | IPR013098 | |
| Domain | I-set | 2.06e-03 | 190 | 174 | 7 | PF07679 | |
| Domain | Ig_C1-set | 2.09e-03 | 58 | 174 | 4 | IPR003597 | |
| Domain | P_TREFOIL_1 | 2.33e-03 | 8 | 174 | 2 | PS00025 | |
| Domain | PH-BEACH_dom | 2.33e-03 | 8 | 174 | 2 | IPR023362 | |
| Domain | - | 2.33e-03 | 8 | 174 | 2 | 2.30.29.40 | |
| Domain | Trefoil | 2.33e-03 | 8 | 174 | 2 | PF00088 | |
| Domain | PH_BEACH | 2.33e-03 | 8 | 174 | 2 | PS51783 | |
| Domain | P_trefoil_CS | 2.33e-03 | 8 | 174 | 2 | IPR017957 | |
| Domain | BEACH | 2.98e-03 | 9 | 174 | 2 | PS50197 | |
| Domain | Beach | 2.98e-03 | 9 | 174 | 2 | PF02138 | |
| Domain | - | 2.98e-03 | 9 | 174 | 2 | 1.10.1540.10 | |
| Domain | P_TREFOIL_2 | 2.98e-03 | 9 | 174 | 2 | PS51448 | |
| Domain | Beach | 2.98e-03 | 9 | 174 | 2 | SM01026 | |
| Domain | BEACH_dom | 2.98e-03 | 9 | 174 | 2 | IPR000409 | |
| Domain | RFX_DNA_binding | 2.98e-03 | 9 | 174 | 2 | PF02257 | |
| Domain | DNA-bd_RFX | 2.98e-03 | 9 | 174 | 2 | IPR003150 | |
| Domain | RFX_DBD | 2.98e-03 | 9 | 174 | 2 | PS51526 | |
| Domain | PD | 2.98e-03 | 9 | 174 | 2 | SM00018 | |
| Domain | WD40 | 3.01e-03 | 259 | 174 | 8 | PF00400 | |
| Domain | - | 4.09e-03 | 333 | 174 | 9 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 4.26e-03 | 335 | 174 | 9 | IPR015943 | |
| Domain | - | 4.49e-03 | 11 | 174 | 2 | 4.10.110.10 | |
| Domain | ConA-like_dom | 4.51e-03 | 219 | 174 | 7 | IPR013320 | |
| Domain | PTPc | 4.53e-03 | 36 | 174 | 3 | SM00194 | |
| Domain | P_trefoil_dom | 5.36e-03 | 12 | 174 | 2 | IPR000519 | |
| Domain | TYR_PHOSPHATASE_PTP | 5.68e-03 | 39 | 174 | 3 | PS50055 | |
| Domain | - | 5.68e-03 | 39 | 174 | 3 | 2.120.10.30 | |
| Domain | EGF_CA | 5.72e-03 | 122 | 174 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 6.12e-03 | 124 | 174 | 5 | IPR001881 | |
| Domain | Kelch_2 | 6.29e-03 | 13 | 174 | 2 | IPR011498 | |
| Pubmed | 1.32e-07 | 3 | 178 | 3 | 36011023 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 1.32e-07 | 3 | 178 | 3 | 25576386 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 5.25e-07 | 4 | 178 | 3 | 31833031 | |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 9267806 | ||
| Pubmed | 7.22e-07 | 313 | 178 | 11 | 20800603 | ||
| Pubmed | HKDC1 RFX1 NOMO1 TWF1 LENG8 CNOT9 NOMO2 PTPRS TBC1D1 FGF3 LRP6 UNK DIXDC1 WDFY3 PNPLA7 ZKSCAN4 ANKRD33B NOMO3 HSP90AA1 | 1.13e-06 | 1006 | 178 | 19 | 15226823 | |
| Pubmed | Genetic variations and treatments that affect the lifespan of the NPC1 mouse. | 1.31e-06 | 5 | 178 | 3 | 18077828 | |
| Pubmed | A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway. | PCSK5 RNF31 CACNA2D2 PJA2 FREM2 TRMT6 IGHA1 CNOT9 IQCB1 SHARPIN | 3.96e-06 | 302 | 178 | 10 | 30561431 |
| Pubmed | RNF31 AHCTF1 PDCD2L SCEL TEP1 SP110 INO80D LDLR ZNF8 PJA2 ZZZ3 WIZ SMG7 MCM3AP WDFY3 PADI2 PHIP PCM1 SENP7 | 5.07e-06 | 1116 | 178 | 19 | 31753913 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | COL7A1 VWF CACNA2D2 DUOX2 CHD7 SEC31A TENM2 FREM2 KLHL23 CRYBG1 PHIP NOMO3 PCM1 | 6.01e-06 | 552 | 178 | 13 | 10737800 |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 7.24e-06 | 8 | 178 | 3 | 15257293 | |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 1.08e-05 | 9 | 178 | 3 | 36261522 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | AHCTF1 CHD7 RFX1 ZNF8 ZNF12 TRMT6 RNF2 WIZ BOP1 ZKSCAN4 HCFC1 PHIP SENP7 | 1.67e-05 | 608 | 178 | 13 | 36089195 |
| Pubmed | Hepatic lipase maturation: a partial proteome of interacting factors. | 1.87e-05 | 31 | 178 | 4 | 19136429 | |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 2.11e-05 | 11 | 178 | 3 | 32820719 | |
| Pubmed | 2.14e-05 | 162 | 178 | 7 | 25826454 | ||
| Pubmed | 2.60e-05 | 167 | 178 | 7 | 22159717 | ||
| Pubmed | Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice. | 2.60e-05 | 2 | 178 | 2 | 19273907 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 15169895 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 18752326 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 30730306 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 8620001 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 18029360 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 15831807 | ||
| Pubmed | The association between insulin and low-density lipoprotein receptors. | 2.60e-05 | 2 | 178 | 2 | 22278734 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 21224078 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 29317724 | ||
| Pubmed | Leukocyte ABCA1 remains atheroprotective in splenectomized LDL receptor knockout mice. | 2.60e-05 | 2 | 178 | 2 | 23133551 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 34793833 | ||
| Pubmed | The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue. | 2.60e-05 | 2 | 178 | 2 | 24506864 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 21570975 | ||
| Pubmed | LRP6 protein regulates low density lipoprotein (LDL) receptor-mediated LDL uptake. | 2.60e-05 | 2 | 178 | 2 | 22128165 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 23814116 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 16581003 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 19709745 | ||
| Pubmed | Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. | 2.60e-05 | 2 | 178 | 2 | 11972062 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 16204055 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 33494008 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 16928680 | ||
| Pubmed | A missense variant in SHARPIN mediates Alzheimer's disease-specific brain damages. | 2.60e-05 | 2 | 178 | 2 | 34785643 | |
| Pubmed | Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. | 2.60e-05 | 2 | 178 | 2 | 11520791 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 34227185 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 26489464 | ||
| Pubmed | 3.51e-05 | 175 | 178 | 7 | 28071719 | ||
| Pubmed | GABRD ATP6V0A1 VWF POLG SEC31A CBFB SHROOM2 RPH3A WIZ NOMO2 ATRNL1 SHARPIN DLG1 WDFY3 WDR17 PADI2 PCM1 HSP90AA1 PINK1 | 3.57e-05 | 1285 | 178 | 19 | 35914814 | |
| Pubmed | CHD7 SEC31A TENM2 ATF6B RPH3A TWF1 KCNA2 WIZ ZKSCAN1 PTPRS DLG1 DIXDC1 WDFY3 UNC13A PCM1 HSP90AA1 | 3.92e-05 | 963 | 178 | 16 | 28671696 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 4.49e-05 | 248 | 178 | 8 | 24006456 | |
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 4.60e-05 | 14 | 178 | 3 | 17389516 | |
| Pubmed | 5.73e-05 | 15 | 178 | 3 | 19961580 | ||
| Pubmed | 5.77e-05 | 257 | 178 | 8 | 16335952 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 26520906 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 26241338 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 26034040 | ||
| Pubmed | Involvement of RFX proteins in transcriptional activation from a Ras-responsive enhancer element. | 7.79e-05 | 3 | 178 | 2 | 15024578 | |
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 12411430 | ||
| Pubmed | RFX transcription factors are essential for hearing in mice. | 7.79e-05 | 3 | 178 | 2 | 26469318 | |
| Pubmed | Chd7 deficiency delays leukemogenesis in mice induced by Cbfb-MYH11. | 7.79e-05 | 3 | 178 | 2 | 29018080 | |
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 32160132 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 24821091 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 18006857 | ||
| Pubmed | Linear Ubiquitin Code: Its Writer, Erasers, Decoders, Inhibitors, and Implications in Disorders. | 7.79e-05 | 3 | 178 | 2 | 32403254 | |
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 10330134 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 29500407 | ||
| Pubmed | Ciliogenic RFX transcription factors regulate FGF1 gene promoter. | 7.79e-05 | 3 | 178 | 2 | 22415835 | |
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 20489161 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 28007459 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 23739867 | ||
| Pubmed | Valves of the deep venous system: an overlooked risk factor. | 7.79e-05 | 3 | 178 | 2 | 19436051 | |
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 21705806 | ||
| Pubmed | Serine 165 phosphorylation of SHARPIN regulates the activation of NF-κB. | 7.79e-05 | 3 | 178 | 2 | 33392484 | |
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 24833800 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 35778407 | ||
| Pubmed | ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet. | 7.79e-05 | 3 | 178 | 2 | 18924609 | |
| Pubmed | Drosophila regulatory factor X is necessary for ciliated sensory neuron differentiation. | 7.79e-05 | 3 | 178 | 2 | 12403718 | |
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 3066742 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 27199450 | ||
| Pubmed | Interplay of RFX transcription factors 1, 2 and 3 in motile ciliogenesis. | 7.79e-05 | 3 | 178 | 2 | 32725242 | |
| Pubmed | Identification and molecular analysis of RNF31 Q622H germline polymorphism. | 7.79e-05 | 3 | 178 | 2 | 36276481 | |
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 20675372 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 34829999 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 20229095 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 24311381 | ||
| Pubmed | Augmented atherogenesis in LDL receptor deficient mice lacking both macrophage ABCA1 and ApoE. | 7.79e-05 | 3 | 178 | 2 | 22022523 | |
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 17992262 | ||
| Pubmed | Distinct cerebellar foliation anomalies in a CHD7 haploinsufficient mouse model of CHARGE syndrome. | 7.79e-05 | 3 | 178 | 2 | 29168327 | |
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 31868000 | ||
| Pubmed | Structural basis for ligase-specific conjugation of linear ubiquitin chains by HOIP. | 7.79e-05 | 3 | 178 | 2 | 24141947 | |
| Pubmed | ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. | 7.79e-05 | 3 | 178 | 2 | 20488992 | |
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 22403608 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 8289803 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 34965468 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 21071707 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 16122883 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 28481331 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 30867470 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CACNA2D2 INPP5A POLG INSR POMT1 TARS2 TEP1 SHROOM2 NRP1 PTPN4 SMG7 PTPRS SH3PXD2A SLC19A1 TBC1D1 KLHL23 DLG1 PNPLA7 PCM1 INVS | 8.32e-05 | 1489 | 178 | 20 | 28611215 |
| Pubmed | 1.55e-04 | 4 | 178 | 2 | 29694895 | ||
| Pubmed | 1.55e-04 | 4 | 178 | 2 | 11682486 | ||
| Pubmed | Differential expression of Rfx1-4 during mouse spermatogenesis. | 1.55e-04 | 4 | 178 | 2 | 19596083 | |
| Pubmed | 1.55e-04 | 4 | 178 | 2 | 26517695 | ||
| GeneFamily | Fibronectin type III domain containing | 2.21e-07 | 160 | 129 | 10 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.57e-04 | 161 | 129 | 7 | 593 | |
| GeneFamily | Immunoglobulin like domain containing | 4.73e-04 | 193 | 129 | 7 | 594 | |
| GeneFamily | WD repeat domain containing | 5.89e-04 | 262 | 129 | 8 | 362 | |
| GeneFamily | Regulatory factor X family | 1.38e-03 | 8 | 129 | 2 | 1153 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.76e-03 | 9 | 129 | 2 | 1230 | |
| GeneFamily | Synaptotagmin like tandem C2 proteins | 2.19e-03 | 10 | 129 | 2 | 822 | |
| GeneFamily | TLC domain containing | 2.19e-03 | 10 | 129 | 2 | 1374 | |
| GeneFamily | C1-set domain containing | 3.32e-03 | 42 | 129 | 3 | 591 | |
| GeneFamily | Kelch like|BTB domain containing | 3.32e-03 | 42 | 129 | 3 | 617 | |
| GeneFamily | ATAC complex | 3.74e-03 | 13 | 129 | 2 | 1058 | |
| GeneFamily | Low density lipoprotein receptors | 3.74e-03 | 13 | 129 | 2 | 634 | |
| Coexpression | GSE17721_0.5H_VS_12H_POLYIC_BMDC_UP | PCSK5 SLC17A2 STARD4 GALT FUOM NDUFS2 PTH1R PTPRS DLG1 PADI2 | 1.14e-06 | 200 | 177 | 10 | M4084 |
| Coexpression | GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP | 8.22e-06 | 197 | 177 | 9 | M3136 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP | 9.28e-06 | 200 | 177 | 9 | M9922 | |
| Coexpression | GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_DN | 9.28e-06 | 200 | 177 | 9 | M9763 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C4 | 4.80e-05 | 11 | 177 | 3 | M566 | |
| Coexpression | GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP | 4.89e-05 | 191 | 177 | 8 | M4164 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 6.53e-05 | 199 | 177 | 8 | M9124 | |
| Coexpression | GSE33424_CD161_INT_VS_NEG_CD8_TCELL_DN | 6.77e-05 | 200 | 177 | 8 | M8553 | |
| Coexpression | GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN | 6.77e-05 | 200 | 177 | 8 | M8476 | |
| Coexpression | GSE21379_WT_VS_SAP_KO_CD4_TCELL_UP | 6.77e-05 | 200 | 177 | 8 | M7499 | |
| Coexpression | GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN | 6.77e-05 | 200 | 177 | 8 | M6246 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.13e-06 | 193 | 178 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.43e-06 | 199 | 178 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.43e-06 | 199 | 178 | 8 | d95d78b2ebc9a20532466e4d4be579b4faf6776f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.43e-06 | 199 | 178 | 8 | cdcfca94baba66e213cc3ffb0cfb4c75d6ab44ec | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.43e-06 | 199 | 178 | 8 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Leuk-UTI-Myeloid-tDC|Leuk-UTI / Disease, Lineage and Cell Type | 3.94e-06 | 161 | 178 | 7 | 51b9f60986ed2e8e2297d31c80462c3ab65a2e5e | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-06 | 176 | 178 | 7 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-06 | 176 | 178 | 7 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 9.45e-06 | 184 | 178 | 7 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 9.78e-06 | 185 | 178 | 7 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.05e-05 | 187 | 178 | 7 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.05e-05 | 187 | 178 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | B_cells-Naive_B_cells_|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.09e-05 | 188 | 178 | 7 | d1bc1316bbb8cfc39acc70f8680b14d19f536997 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-05 | 188 | 178 | 7 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.09e-05 | 188 | 178 | 7 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 1.20e-05 | 191 | 178 | 7 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-Memory_B_cells|GI_large-bowel / Manually curated celltypes from each tissue | 1.25e-05 | 192 | 178 | 7 | 31f7245bce79969674a775ecf175e7c6af68b503 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 193 | 178 | 7 | a5695ce2e24a62026ae28f3dea07ca4a435206b8 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.29e-05 | 193 | 178 | 7 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Thalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.29e-05 | 193 | 178 | 7 | 712a4acd1167e43543950bc819ff11984e6f718d | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 1.33e-05 | 194 | 178 | 7 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 195 | 178 | 7 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-05 | 197 | 178 | 7 | 76465bb2408c7c75f694e8f7cf1a606b796afc3a | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.47e-05 | 197 | 178 | 7 | 99fe44ef42c65d24fe64947fd5bf6d91b9a4b2c3 | |
| ToppCell | Biopsy_IPF-Immune-B_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 1.52e-05 | 198 | 178 | 7 | 6a519337a4932a7b685fe7defd3de24fa2016b7d | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.52e-05 | 198 | 178 | 7 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Sepsis-Leuk-UTI-Myeloid-tDC|Leuk-UTI / Disease, condition lineage and cell class | 1.57e-05 | 199 | 178 | 7 | a2f154b15087803958a656d2a41b6d83fd37b32f | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 200 | 178 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 200 | 178 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 200 | 178 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-05 | 158 | 178 | 6 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-05 | 158 | 178 | 6 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 4.36e-05 | 159 | 178 | 6 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 4.36e-05 | 159 | 178 | 6 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 160 | 178 | 6 | a494001b1f6dec33624f98fa3c24bad6988d0425 | |
| ToppCell | (1)_Control_(PBS)-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 4.51e-05 | 160 | 178 | 6 | ab769516f9f7798d1390ef215caf22a2d3d53e63 | |
| ToppCell | Healthy_Control-Lymphoid-B-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.00e-05 | 163 | 178 | 6 | d84bd41b4494c7d5c7f88d511bfe481fb12f079d | |
| ToppCell | Healthy_Control-Lymphoid-B|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.00e-05 | 163 | 178 | 6 | 0f723ec2503afa1b3ebb0754972438ffb6e6179d | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 5.73e-05 | 167 | 178 | 6 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 6.32e-05 | 170 | 178 | 6 | 4a19c7e3bb0f9c2601a10debe7000066789b4150 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.53e-05 | 171 | 178 | 6 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.53e-05 | 171 | 178 | 6 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | 10x5'-Liver-Lymphocytic_B-ABC_aged-B_memory|Liver / Manually curated celltypes from each tissue | 6.53e-05 | 171 | 178 | 6 | eb47f4a09a630ed14a0898377039ed50ef7cc292 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 172 | 178 | 6 | 7295bf3ae21a61dd6bcfa0dfb7a37d0f3e8f94ab | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.19e-05 | 174 | 178 | 6 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_26.46.91|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.42e-05 | 175 | 178 | 6 | 3031f1eef3cfef8a7e5f57e567cb0868d06cac38 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.66e-05 | 176 | 178 | 6 | 941e8724b6f680719ef2a4f190f943b205bb9e78 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_activate-7|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.66e-05 | 176 | 178 | 6 | dde46f06f6fc3f7ba83be91a0ee6231790955e3e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.90e-05 | 177 | 178 | 6 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.15e-05 | 178 | 178 | 6 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 178 | 178 | 6 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.40e-05 | 179 | 178 | 6 | c833ded1f9e87be2ba2037820d92a389560b711c | |
| ToppCell | IPF-Lymphoid-B|World / Disease state, Lineage and Cell class | 8.66e-05 | 180 | 178 | 6 | 30f9398c9b784f49470847a025bac90687e997a1 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.93e-05 | 181 | 178 | 6 | f6629fa71bb94405f523f63a9264cacf6d15c5f4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.93e-05 | 181 | 178 | 6 | 6cdee2f56bc633b387b4dbbd78c624edbd712c24 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.93e-05 | 181 | 178 | 6 | b75b8b025257bccfe661fd0f92ab284b2a9c12ee | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype|TCGA-Lung / Sample_Type by Project: Shred V9 | 8.93e-05 | 181 | 178 | 6 | c783c2ecca7ab8e07646fa92dc7d436d24939d03 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.93e-05 | 181 | 178 | 6 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B-B|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.21e-05 | 182 | 178 | 6 | dc6b5ce410c1a7cade60ae17cbbe8548c088cba8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.21e-05 | 182 | 178 | 6 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B|Lung / Manually curated celltypes from each tissue | 9.21e-05 | 182 | 178 | 6 | 310f94437d197eaaaf6e30e68063b33e94befe77 | |
| ToppCell | IPF-Lymphoid-B|IPF / Disease state, Lineage and Cell class | 9.49e-05 | 183 | 178 | 6 | e37d2c015c34471a8a54a0299e94b0371e1ada5a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.49e-05 | 183 | 178 | 6 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|lung / Disease (COVID-19 only), tissue and cell type | 9.78e-05 | 184 | 178 | 6 | 480595a0e2e6aa2a77b7daa36490ae3af3d8dfee | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 9.78e-05 | 184 | 178 | 6 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 9.78e-05 | 184 | 178 | 6 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 185 | 178 | 6 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 185 | 178 | 6 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 185 | 178 | 6 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 185 | 178 | 6 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | COPD-Lymphoid-B|World / Disease state, Lineage and Cell class | 1.01e-04 | 185 | 178 | 6 | 22891ed75e25ef30dfa541cb82d85e08ce07e7d9 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-04 | 186 | 178 | 6 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 1.04e-04 | 186 | 178 | 6 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | IPF-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 1.04e-04 | 186 | 178 | 6 | 962c2dada19185628ead77c32fcb07fa95114247 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 186 | 178 | 6 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-04 | 187 | 178 | 6 | 6f7f293c9cf35261e0e3614e46ec1fb00a701b63 | |
| ToppCell | IPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 1.10e-04 | 188 | 178 | 6 | 47bb6caf84f70a1cda7d09803afdfd5182772e66 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.10e-04 | 188 | 178 | 6 | d5ce3ffe783c322b4765b790e861727e46bc34b3 | |
| ToppCell | IPF-Myeloid-cDC1|IPF / Disease state, Lineage and Cell class | 1.10e-04 | 188 | 178 | 6 | 2331a2bae1383820d598e93aa86c75b101069bac | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-04 | 118 | 178 | 5 | 08bdf7bc3c9dcbc0f690658fe14e6cc4b9581698 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-04 | 118 | 178 | 5 | 3b077ad5c68c01b3fcc93f203cb130bb90705af9 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 1.13e-04 | 189 | 178 | 6 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.13e-04 | 189 | 178 | 6 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 190 | 178 | 6 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.17e-04 | 190 | 178 | 6 | ce70336679a2b713836e7497e6dc48aac612b018 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-04 | 190 | 178 | 6 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 191 | 178 | 6 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-04 | 191 | 178 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-04 | 191 | 178 | 6 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-04 | 191 | 178 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-04 | 191 | 178 | 6 | ce0217d375af6b19252a45340b72241ea7b204d4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 191 | 178 | 6 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.20e-04 | 191 | 178 | 6 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Memory_B_cells|bone_marrow / Manually curated celltypes from each tissue | 1.20e-04 | 191 | 178 | 6 | 67479df0ca4c5a792fd604aded3f75609fec0888 | |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 1.20e-04 | 191 | 178 | 6 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.20e-04 | 191 | 178 | 6 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 1.23e-04 | 192 | 178 | 6 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.23e-04 | 192 | 178 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 1.23e-04 | 192 | 178 | 6 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 1.23e-04 | 192 | 178 | 6 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| Drug | leucrose | 4.32e-07 | 9 | 177 | 4 | CID000165577 | |
| Drug | NSC624987 | 6.35e-07 | 22 | 177 | 5 | CID000001472 | |
| Drug | nectrisine | 7.15e-07 | 10 | 177 | 4 | CID000122106 | |
| Drug | valiolamine | 2.39e-06 | 13 | 177 | 4 | CID000174312 | |
| Drug | MDL 25,637 | 2.39e-06 | 13 | 177 | 4 | CID000128548 | |
| Drug | 2ai8 | 4.51e-06 | 15 | 177 | 4 | CID005289329 | |
| Drug | AC1OAGYH | 4.51e-06 | 15 | 177 | 4 | CID006857622 | |
| Drug | D-gluco-octenitol | 4.57e-06 | 5 | 177 | 3 | CID006438548 | |
| Drug | (-)-Lentiginosine | 4.57e-06 | 5 | 177 | 3 | CID000130407 | |
| Drug | pulmatin | 4.57e-06 | 5 | 177 | 3 | CID000442731 | |
| Drug | homonojirimycin | 7.76e-06 | 17 | 177 | 4 | CID000159496 | |
| Drug | AC1OCFTL | 9.08e-06 | 6 | 177 | 3 | CID006918743 | |
| Drug | miglustat | 1.09e-05 | 97 | 177 | 7 | CID000051634 | |
| Drug | nojirimycin | 1.09e-05 | 38 | 177 | 5 | CID000065242 | |
| Drug | cyclophellitol | 1.25e-05 | 19 | 177 | 4 | CID000164227 | |
| Drug | silver hydride | 1.55e-05 | 20 | 177 | 4 | CID000139654 | |
| Drug | Mor-502 | 1.58e-05 | 7 | 177 | 3 | CID003080955 | |
| Drug | heptenitol | 1.58e-05 | 7 | 177 | 3 | CID000188267 | |
| Drug | isomaltotetraose | 1.58e-05 | 7 | 177 | 3 | CID003080783 | |
| Drug | I0329 | 1.91e-05 | 21 | 177 | 4 | CID000439668 | |
| Drug | Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.38e-05 | 196 | 177 | 9 | 4416_DN | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 2.48e-05 | 197 | 177 | 9 | 6867_UP | |
| Drug | 3,4,5-triCQA | 2.51e-05 | 8 | 177 | 3 | CID006440783 | |
| Drug | casuarictin | 2.51e-05 | 8 | 177 | 3 | CID000073644 | |
| Drug | Solasodine [126-17-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | 2.58e-05 | 198 | 177 | 9 | 3749_DN | |
| Drug | Convolamine hydrochloride [500-56-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.68e-05 | 199 | 177 | 9 | 5876_DN | |
| Drug | N-phenylphthalimide | 5.33e-05 | 10 | 177 | 3 | CID000068215 | |
| Drug | AC1L3M0Q | 5.33e-05 | 10 | 177 | 3 | CID000118008 | |
| Drug | Dfj | 5.33e-05 | 10 | 177 | 3 | CID009549198 | |
| Drug | trehazolin | 5.33e-05 | 10 | 177 | 3 | CID003081797 | |
| Drug | Miglitol | 6.01e-05 | 2 | 177 | 2 | DB00491 | |
| Drug | AC1L970Z | 7.20e-05 | 29 | 177 | 4 | CID000439275 | |
| Drug | glucosyl fluoride | 7.28e-05 | 11 | 177 | 3 | CID000150967 | |
| Drug | trehalulose | 7.28e-05 | 11 | 177 | 3 | CID000162104 | |
| Drug | AC1NUSO2 | 7.28e-05 | 11 | 177 | 3 | CID005460006 | |
| Drug | nicotinoylprocaine | 9.65e-05 | 12 | 177 | 3 | CID000159667 | |
| Drug | phosphomevalonate | 1.21e-04 | 33 | 177 | 4 | CID000000476 | |
| Drug | colestimide | 1.25e-04 | 13 | 177 | 3 | CID000065840 | |
| Drug | methyl 1'-epiacarviosin | 1.25e-04 | 13 | 177 | 3 | CID000197426 | |
| Drug | isoacarbose | 1.25e-04 | 13 | 177 | 3 | CID000449165 | |
| Drug | galloylglucose | 1.25e-04 | 13 | 177 | 3 | CID000124375 | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.34e-04 | 192 | 177 | 8 | 4743_DN | |
| Drug | NSC625381 | 1.43e-04 | 145 | 177 | 7 | CID000002592 | |
| Drug | haloperidol; Down 200; 10uM; HL60; HT_HG-U133A | 1.49e-04 | 195 | 177 | 8 | 1144_DN | |
| Drug | Diethylstilbestrol [56-53-1]; Up 200; 15uM; PC3; HT_HG-U133A | 1.54e-04 | 196 | 177 | 8 | 4547_UP | |
| Drug | tempo-maleimide | 1.58e-04 | 14 | 177 | 3 | CID002724304 | |
| Drug | Metronidazole [443-48-1]; Up 200; 23.4uM; MCF7; HT_HG-U133A | 1.59e-04 | 197 | 177 | 8 | 1503_UP | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.59e-04 | 197 | 177 | 8 | 7012_DN | |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; HL60; HT_HG-U133A | 1.59e-04 | 197 | 177 | 8 | 2903_DN | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; PC3; HT_HG-U133A | 1.59e-04 | 197 | 177 | 8 | 1810_DN | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 1.59e-04 | 197 | 177 | 8 | 3202_DN | |
| Drug | Norfloxacin [70458-96-7]; Down 200; 12.6uM; HL60; HG-U133A | 1.59e-04 | 197 | 177 | 8 | 1406_DN | |
| Drug | Chlorphensin carbamate [886-74-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 1.59e-04 | 197 | 177 | 8 | 7472_DN | |
| Drug | Adrenosterone [382-45-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 177 | 8 | 6486_DN | |
| Drug | Metformin hydrochloride [1115-70-4]; Down 200; 24.2uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 177 | 8 | 5487_DN | |
| Drug | Fenofibrate [49562-28-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 177 | 8 | 7474_DN | |
| Drug | Nafronyl oxalate [3200-06-4]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.65e-04 | 198 | 177 | 8 | 6687_DN | |
| Drug | Ioversol [87771-40-2]; Up 200; 5uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 177 | 8 | 5326_UP | |
| Drug | Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.65e-04 | 198 | 177 | 8 | 4316_UP | |
| Drug | Aminophylline [317-34-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.71e-04 | 199 | 177 | 8 | 5395_UP | |
| Drug | Ricinine [524-40-3]; Down 200; 24.4uM; MCF7; HT_HG-U133A | 1.77e-04 | 200 | 177 | 8 | 6206_DN | |
| Drug | Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.77e-04 | 200 | 177 | 8 | 3442_DN | |
| Drug | 7-deoxy-6-epi-castanospermine | 1.79e-04 | 3 | 177 | 2 | CID000125391 | |
| Drug | AC1NUR2V | 1.79e-04 | 3 | 177 | 2 | CID005489114 | |
| Drug | glucono-delta-lactam | 1.79e-04 | 3 | 177 | 2 | CID000151939 | |
| Drug | callyspongynic acid | 1.79e-04 | 3 | 177 | 2 | CID000636783 | |
| Drug | IPG7F | 1.79e-04 | 3 | 177 | 2 | CID003083273 | |
| Drug | dibutylmagnesium | 1.79e-04 | 3 | 177 | 2 | CID000070929 | |
| Drug | Pradimicin Q | 1.79e-04 | 3 | 177 | 2 | CID000073572 | |
| Drug | 3-nitro-4-(6-aminohexylamido)phenylboronic acid | 1.79e-04 | 3 | 177 | 2 | CID000133488 | |
| Drug | AC1L1I1D | 1.91e-04 | 37 | 177 | 4 | CID000004381 | |
| Drug | Valimon | 1.96e-04 | 15 | 177 | 3 | CID000037716 | |
| Disease | Cleft palate, isolated | 1.07e-04 | 42 | 173 | 4 | C1837218 | |
| Disease | platelet-to-lymphocyte ratio | 3.09e-04 | 363 | 173 | 9 | EFO_0008446 | |
| Disease | Huntington disease, disease progression measurement | 7.16e-04 | 30 | 173 | 3 | EFO_0008336, MONDO_0007739 | |
| Disease | fatty liver disease (implicated_via_orthology) | 7.89e-04 | 31 | 173 | 3 | DOID:9452 (implicated_via_orthology) | |
| Disease | pantothenate measurement | 9.35e-04 | 8 | 173 | 2 | EFO_0021034 | |
| Disease | Cleft Palate | 1.34e-03 | 81 | 173 | 4 | C0008925 | |
| Disease | lactate measurement | 1.55e-03 | 39 | 173 | 3 | EFO_0007745 | |
| Disease | Hypercholesterolemia | 1.55e-03 | 39 | 173 | 3 | C0020443 | |
| Disease | Takayasu arteritis | 1.84e-03 | 148 | 173 | 5 | EFO_1001857 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.07e-03 | 301 | 173 | 7 | DOID:684 (is_marker_for) | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 2.17e-03 | 12 | 173 | 2 | C0403553 | |
| Disease | Schizophrenia | GABRD ABCA1 INPP5A DCC ZNF804A SLC26A8 SH3PXD2A MICB DLG1 DIXDC1 ZKSCAN4 PCM1 PINK1 | 2.20e-03 | 883 | 173 | 13 | C0036341 |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 2.55e-03 | 13 | 173 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | Hyperlipoproteinemia Type IIb | 2.55e-03 | 13 | 173 | 2 | C1704417 | |
| Disease | respiratory quotient | 2.97e-03 | 14 | 173 | 2 | EFO_0005189 | |
| Disease | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | 2.99e-03 | 49 | 173 | 3 | EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.99e-03 | 49 | 173 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | mitochondrial DNA measurement | 3.33e-03 | 328 | 173 | 7 | EFO_0006312 | |
| Disease | chenodeoxycholate measurement | 3.41e-03 | 15 | 173 | 2 | EFO_0010471 | |
| Disease | cleft lip (is_implicated_in) | 3.41e-03 | 15 | 173 | 2 | DOID:9296 (is_implicated_in) | |
| Disease | glucose metabolism measurement, age-related hearing impairment | 3.55e-03 | 52 | 173 | 3 | EFO_0005782, EFO_0009367 | |
| Disease | complement C4 measurement | 3.55e-03 | 52 | 173 | 3 | EFO_0004984 | |
| Disease | mortality | 3.61e-03 | 173 | 173 | 5 | EFO_0004352 | |
| Disease | Dupuytren Contracture | 3.81e-03 | 108 | 173 | 4 | EFO_0004229 | |
| Disease | Hyperlipoproteinemia Type IIa | 3.89e-03 | 16 | 173 | 2 | C0745103 | |
| Disease | triglycerides in LDL measurement | 4.37e-03 | 56 | 173 | 3 | EFO_0022320 | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 4.39e-03 | 17 | 173 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | apolipoprotein A 1 measurement | MGAM COL7A1 ABCA1 PROCR ITGA10 LDLR NRP1 PJA2 BTNL3 UGT2B10 NUDC PHIP | 4.43e-03 | 848 | 173 | 12 | EFO_0004614 |
| Disease | Drug habituation | 4.76e-03 | 115 | 173 | 4 | C0013170 | |
| Disease | Drug abuse | 4.76e-03 | 115 | 173 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 4.76e-03 | 115 | 173 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 4.76e-03 | 115 | 173 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 4.76e-03 | 115 | 173 | 4 | C0013222 | |
| Disease | Drug Dependence | 4.76e-03 | 115 | 173 | 4 | C1510472 | |
| Disease | Substance Dependence | 4.76e-03 | 115 | 173 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 4.76e-03 | 115 | 173 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 4.76e-03 | 115 | 173 | 4 | C0029231 | |
| Disease | IGA glomerulonephritis | 4.82e-03 | 58 | 173 | 3 | EFO_0004194 | |
| Disease | Substance abuse problem | 4.91e-03 | 116 | 173 | 4 | C0740858 | |
| Disease | Hypercholesterolemia, Familial | 4.92e-03 | 18 | 173 | 2 | C0020445 | |
| Disease | cardiomyopathy (is_implicated_in) | 5.47e-03 | 19 | 173 | 2 | DOID:0050700 (is_implicated_in) | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 5.47e-03 | 19 | 173 | 2 | DOID:4928 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RTKTIYGNLNPVWEE | 711 | Q9UPW8 | |
| DIRNTVGNVPLEWYD | 131 | Q14137 | |
| GPEQAQTSYRDLWSL | 426 | Q8N350 | |
| PESWARTQSGLQSYL | 76 | Q9UNN8 | |
| LSPNNGYWVLRLTTE | 371 | Q6UXE8 | |
| GILQALTTEAYEWEP | 51 | Q96FG2 | |
| TWVPIRSTNYSLGLV | 626 | Q9NY47 | |
| SPGTYLETSWEEQLL | 271 | Q155Q3 | |
| QIIEEQSGSYIWVPA | 886 | Q12959 | |
| STYPELQLPTVWREN | 241 | Q96PJ5 | |
| PEDVQSSNGSVYTWR | 471 | O95477 | |
| KIYQWINELSSPETR | 21 | Q92600 | |
| PQEVEYWILIGESSR | 351 | Q86UB2 | |
| LEGQDIILYWRNPTS | 286 | P29016 | |
| SSPYIQVLEEDWRQA | 276 | Q9H257 | |
| AELGQLYWPNTSTLT | 1896 | Q9P2D1 | |
| WLFGYDEQRQPLTVE | 216 | Q9NT62 | |
| SPQEWATYTGRVDAV | 226 | A6NCL7 | |
| GNVITSSEYLPTLWV | 1061 | P69849 | |
| EIAGIPYSLQIWDTA | 166 | O95755 | |
| ESRPLTQIQYIAWPD | 806 | P29074 | |
| YGPATQVRWLQETSK | 1991 | P51610 | |
| QYRSSSLGPVTVQWL | 4741 | Q99102 | |
| GYWPVDTNLIDRSTL | 1061 | P43146 | |
| DILGIWVDPIDSTYQ | 146 | P49441 | |
| GNVITSSEYLPTLWV | 1061 | Q5JPE7 | |
| QRQVWLLFEYPESSG | 146 | P16389 | |
| LDSVETYNPELNVWR | 336 | A6NCF5 | |
| TWLLNGQPIQYARST | 546 | Q15746 | |
| PDPNLEWTQISTRYL | 181 | Q86YW9 | |
| LPTTINYTLWSQSDE | 71 | P43365 | |
| VDWTVSEPRYFQLQT | 431 | Q8IXH7 | |
| LLVSLQWGREQTYSP | 271 | Q9H2G9 | |
| QWAEGEPRYALTTTL | 181 | Q9HB07 | |
| GWSQTRPTYEAVQEV | 1486 | O43451 | |
| QDGSAYTIDWSREPL | 326 | Q96PV6 | |
| QPSAERLWYVSVNGK | 146 | P11487 | |
| DSTPLFQVALGREWY | 2996 | Q5SZK8 | |
| YDVPLSWEQARLQTQ | 1786 | O60318 | |
| NLTQYSWLLDGFPRT | 81 | Q9UIJ7 | |
| QDALSLPWEVQRYDG | 26 | Q9NRD8 | |
| DTNSLFPGTWYLERV | 481 | P54868 | |
| SSRTPWLYEQEGEVE | 1206 | Q15154 | |
| GDWVLEVYDTPSQLR | 566 | Q92824 | |
| DESIGLQLPFSSWYV | 391 | Q9BXM7 | |
| NLVAWETSPSVYSGI | 191 | Q14642 | |
| QEQILRYSWSGEPLF | 261 | Q9BRP1 | |
| ASWQGEQRQTPSREY | 71 | Q13951 | |
| IGNPETELLVRWYQA | 621 | Q8TET4 | |
| TTWLNPLGIYDQSTT | 266 | Q9H7Z3 | |
| GNVITSSEYLPTLWV | 1061 | Q15155 | |
| ERYSWTSQLSPADLI | 231 | P54098 | |
| SSRFIIINSEIYWPN | 171 | O75581 | |
| IINSEIYWPNGLTLD | 176 | O75581 | |
| YVGSNLEISWLPNLD | 31 | O14764 | |
| LVLAAGSQVQEWYPR | 16 | Q6JVE6 | |
| NYTVIQESPEEGVRW | 296 | Q3SXY7 | |
| YPRNITLTWRQDGVS | 231 | Q29980 | |
| LWEITSLAEQPYQGL | 1226 | P06213 | |
| QASEWVRRTEGQYPS | 1671 | Q9UKK3 | |
| VQAPVELYSDWLTVG | 456 | Q9Y2J8 | |
| TKLLTTPYERQEGWQ | 136 | O77932 | |
| TPYERQEGWQLAASR | 141 | O77932 | |
| YQADGTLTPWTQRCV | 801 | Q6ZV29 | |
| SGIQWDLRKTQPYDV | 296 | O75306 | |
| RLFTIDGISIPYTWN | 5026 | Q96RW7 | |
| GLSPNSEYEIWVSAV | 391 | Q13332 | |
| STLETPQDYIRLWQE | 681 | Q8IV76 | |
| TPGEDSYREWIQVDL | 316 | O14786 | |
| IGAEYSSNVPVWSLR | 91 | Q9Y6A1 | |
| LYVRPSQSGSVDTNW | 261 | Q8NH40 | |
| KERGLQTPVWTEYES | 86 | A2VDF0 | |
| WLYNESPVRGTVVTN | 246 | Q9BTY2 | |
| QYTLVPVSGWQELET | 46 | O75419 | |
| RLGSFETYINPQKWE | 3446 | Q9C0G6 | |
| ILYAGNDRWTSDPRV | 71 | A6NGN9 | |
| QWSIYLPSSPEREVQ | 56 | O75054 | |
| LETNEWRYVSSLPQP | 446 | Q9P2G3 | |
| TNVWIQGAEIPDYTR | 296 | Q8NBE8 | |
| LLSPVSVEWRAQSEY | 206 | P13765 | |
| TLNPVWNEDLTYSGI | 151 | Q14183 | |
| ARLTWDPTSRQINGY | 551 | Q05707 | |
| SVTEELGAQYPWVQI | 156 | P07902 | |
| DPIVNVWYSVNGERL | 31 | Q13347 | |
| QGSQELPREKYLTWA | 266 | P01876 | |
| WQALRTRYGVSPENI | 191 | Q6PCB6 | |
| YNLESSIWNVGTPSR | 336 | Q5VV63 | |
| TWYDLQTVPVEALGS | 771 | P10253 | |
| LTQYQRDFGLWTTPA | 66 | Q9H9H5 | |
| PGEYANDQERRWTLT | 36 | O00187 | |
| VLDGSNSIYPWSEVQ | 171 | O75578 | |
| SEQASPYQVAWSIRE | 336 | Q53TQ3 | |
| LSQDYSRIQGGWTTI | 66 | Q15051 | |
| YRVTWRVLSGGPTQQ | 356 | Q02388 | |
| LTGYIRRWITEEQPN | 561 | Q8WYP5 | |
| IWTRNPDDITNEEYG | 296 | P07900 | |
| SINVLSGVWVAYENP | 1356 | Q9Y4K1 | |
| PYEIWVEATNRLGSA | 206 | O75462 | |
| VQPGEELTVWYSNSL | 101 | Q9H4Q3 | |
| VRELPRGEWQTYSSS | 1516 | Q7Z5N4 | |
| LRAQGSSYTIPEAWL | 361 | Q8IY34 | |
| TSPYLDWTIERVALN | 221 | Q9Y597 | |
| DTLTQISPKEGWQVY | 41 | Q96PB7 | |
| TWELSLYELQRTPQE | 16 | Q99496 | |
| AALGSEVRIWSYTQP | 236 | Q8NAC3 | |
| SLPYSVGRVLSIWSQ | 1876 | Q5THK1 | |
| LQWREPTQTYGVITL | 501 | P28827 | |
| ESLLNWQDYEGRTPL | 211 | Q9Y283 | |
| VNSEIYPLWARSTGN | 531 | Q96QE2 | |
| IDAVAWNTTPYQLAR | 71 | Q9BW92 | |
| SLVQAWPGYTLETAN | 341 | Q6NW40 | |
| TTQPIWGSLYRSLLQ | 21 | Q6PI48 | |
| SGELELSYPLSWVQA | 646 | Q9BQF6 | |
| NPIWNETLVYHGITD | 456 | Q9Y2J0 | |
| GDLPATQLVTWQVEY | 391 | Q14C87 | |
| WSPQLLVYSSTQELQ | 351 | Q7L2K0 | |
| WTRYDTEVDEGSLNP | 721 | Q2TB90 | |
| WQLYGVRESVSPTAQ | 291 | Q9ULZ9 | |
| WLLDNYETAEGVSLP | 441 | P22670 | |
| WLLDNYETAEGVSLP | 186 | P48380 | |
| ETISNLPSLWRQDQY | 471 | Q96RN1 | |
| WVLQDYVSPTLDLSN | 2101 | Q6ZNJ1 | |
| ELATFLGRVDPWYQS | 476 | Q5UE93 | |
| PAEVWTSRQALQDLY | 26 | Q92540 | |
| TVNLQPLEWAYGSSE | 296 | Q9NZC9 | |
| SAENILYTVGLWEAP | 231 | Q13796 | |
| GAVNLEWPLESVSYT | 66 | Q9H0F6 | |
| DSLYNEGILIVWDPS | 246 | P15907 | |
| ILQYSEPQSRFWGRD | 321 | Q9UNP4 | |
| TQRDYDVLAGRWTSP | 2426 | Q9NT68 | |
| TPQDYNLRWSGLLVT | 381 | Q96M27 | |
| WDINTLTAVYTSPGN | 421 | Q8IZU2 | |
| VTEWYVNGSPIDTLR | 1071 | O95785 | |
| VGASYEWQSRDTPIL | 106 | Q9HB58 | |
| VLVQAEYNWITPSVG | 506 | A0A1B0GV85 | |
| GADLPNYRWTQTLSE | 166 | Q9Y266 | |
| LLSPEDWGLQNSTLY | 21 | Q99941 | |
| ALQYSGTEVPLQWLR | 511 | Q96EP0 | |
| RIEWTTPDLGQSALY | 81 | Q8IZ63 | |
| QSEEEGSWLREYPVT | 1856 | Q8IZQ1 | |
| TEWTGLSPAQRALYR | 26 | P17023 | |
| SVLQYGSITTIDVPW | 1731 | P04275 | |
| ALPSTYRSLVWELQQ | 1231 | Q99973 | |
| WFGTIESQEPLQLEY | 1081 | Q8WWQ0 | |
| ATPYTEVSGTLWQVQ | 426 | Q03431 | |
| VSTSEEQGWVPATYL | 206 | Q5TCZ1 | |
| PLENLQAGDSIWIYR | 656 | O95171 | |
| VTEGYLTNPRSLWED | 136 | Q15035 | |
| LWNEVDPTTNSARVY | 291 | P41440 | |
| RSQQWDPLIYSSIFE | 81 | Q86TI0 | |
| WSPETQGIIFSSINY | 86 | O00624 | |
| WVGVQLPRNTTSYVL | 1026 | P24821 | |
| ALRLNWTTPDGTYDQ | 1271 | P24821 | |
| LETQGNLTSSWYNPR | 116 | A8MX80 | |
| QGSRYEPSITVHLWQ | 51 | O95988 | |
| WIYPDRVKGLESSQQ | 76 | Q2M218 | |
| SETWLRNYQVLPDRS | 426 | Q9UJA5 | |
| LETQGNLTSSWYNPR | 86 | A8MV72 | |
| TYNWTEETLRGNPVL | 486 | Q93050 | |
| ATIPLNGTSDTWYQE | 741 | O95049 | |
| ISENYISDPTILWRA | 141 | Q15629 | |
| LETQGNLTSSWYNPR | 116 | Q8N9G6 | |
| TPGWTQLDSSQVNLY | 231 | Q969J2 | |
| LETQGNLTSSWYNPR | 116 | A8MUI8 | |
| LETQGNLTSSWYNPR | 116 | A8MUA0 | |
| QEEWGQLDPTQRILY | 36 | P17098 | |
| WDQFYSEVLGRPTTL | 231 | P36537 | |
| YTTAGQLWNIISPRE | 101 | Q96DR4 | |
| NPSAWVGSVEILLSY | 351 | P22735 | |
| GEFLLQSYPDEVWQT | 71 | P17014 | |
| ELQVWLQEYRPDSGE | 111 | P17029 | |
| VSNGPADTLDLTYWI | 116 | P35442 | |
| NTGEVLYELPTNTQW | 291 | O94979 | |
| QGEELWTQRIFPSYS | 61 | Q96SR6 | |
| SEEPRWQETAYVLGN | 201 | Q9C0B0 | |
| QLPEIVWDQYTHSLG | 561 | Q8IYH5 | |
| EQTSLEEGEIPWLQY | 491 | O43164 | |
| GTDYITPWQLSQVVD | 61 | Q8N8N7 | |
| SITLNLPQDVWLYQS | 336 | Q6YBV0 | |
| PAISWVNNLEVDSRY | 456 | Q9NYU2 | |
| QLVIGSYSQPSDSWD | 36 | Q12792 | |
| LVEAWYSRNVSPGES | 251 | B6A8C7 | |
| ETPTEWLRYNSGILN | 986 | Q7Z570 | |
| STLSPQVTNLNEWYV | 611 | Q96T25 | |
| DIYSLVTENIQWPNG | 551 | P01130 | |
| WSLTEQDPYNNIVRT | 356 | P22033 |